Cara Therapeutics (CARA)
$23.35 0.72 (3.18%)
17:58 EDT CARA Stock Quote Delayed 15 Minutes
Previous Close $23.35
Market Cap 790.98M
PE Ratio -14.97
Volume (Avg. Vol.) 606,600
Day's Range 22.52 - 23.51
52-Week Range 12.19 - 27.55
Dividend & Yield N/A (N/A)
CARA Stock Predictions, Articles, and Cara Therapeutics News
- From InvestorPlace
- From the Web
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.
Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Putting in the work may pay off big for In 2018, setting up the clinical studies dominated Cara Therapeutics' activities. For 2019, the study results may drive Cara stock higher. stock
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.
Marijuana stocks like Cronos, Cannabis Sativa and Canopy Growth are just a handful of the names worth a closer look here.
3 Stocks to Watch on Wednesday: Square Inc (SQ), Cara Therapeutics Inc (CARA) and Healthcare Services Group, Inc. (HCSG)
Square (SQ) continues its breathtaking 2017 rally Wednesday, Cara Therapeutics (CARA) jumps on trial results and Healthcare Services Group (HCSG) scores a post-earnings bump.
Why Best Buy Co Inc (BBY), Abercrombie & Fitch Co. (ANF) and Cara Therapeutics Inc (CARA) Are 3 of Today’s Worst Stocks
Too bad for Cara Therapeutics (CARA), Abercrombie & Fitch (ANF) and Best Buy (BBY) owners -- the market doesn't do do-overs.
Why Pandora Media Inc (P), Cara Therapeutics Inc (CARA) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks
Micron Technology (MU), Pandora (P) and Cara Therapeutics (CARA) all ended the trading week on a bearish foot, but for understandable reasons.
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Cara Therapeutics (CARA) stock was flying high on Friday following good news from the U.S. Food and Drug Administration.
Why Sears Holdings Corp (SHLD), Cara Therapeutics Inc (CARA) and Exxon Mobil Corporation (XOM) Are 3 of Today’s Worst Stocks
Cara Therapeutics (CARA), Sears Holdings (SHLD) and Exxon Mobil (XOM) and the day and the week on a low note, though for understandable reasons.
From Seeking Alpha
From Analyst Ratings
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AnaptysBio Inc (ANAB – Research Report), Autolus Therapeutics Plc (AUTL – Research Report) and Cara Therapeutics (CARA – Research Report) with bullish sentiments. AnaptysBio Inc (ANAB) In a report released today, Andrew Fein from H.C. Wainwright reiterated
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!